1,694 research outputs found
Effect of treatment of gestational diabetes mellitus on pregnancy outcomes
Copyright © 2005 Massachusetts Medical Society.Background: We conducted a randomized clinical trial to determine whether treatment of women with gestational diabetes mellitus reduced the risk of perinatal complications. Methods: We randomly assigned women between 24 and 34 weeks’ gestation who had gestational diabetes to receive dietary advice, blood glucose monitoring, and insulin therapy as needed (the intervention group) or routine care. Primary outcomes included serious perinatal complications (defined as death, shoulder dystocia, bone fracture, and nerve palsy), admission to the neonatal nursery, jaundice requiring phototherapy, induction of labor, cesarean birth, and maternal anxiety, depression, and health status. Results: The rate of serious perinatal complications was significantly lower among the infants of the 490 women in the intervention group than among the infants of the 510 women in the routine-care group (1 percent vs. 4 percent; relative risk adjusted for maternal age, race or ethnic group, and parity, 0.33; 95 percent confidence interval, 0.14 to 0.75; P=0.01). However, more infants of women in the intervention group were admitted to the neonatal nursery (71 percent vs. 61 percent; adjusted relative risk, 1.13; 95 percent confidence interval, 1.03 to 1.23; P=0.01). Women in the intervention group had a higher rate of induction of labor than the women in the routine-care group (39 percent vs. 29 percent; adjusted relative risk, 1.36; 95 percent confidence interval, 1.15 to 1.62; P<0.001), although the rates of cesarean delivery were similar (31 percent and 32 percent, respectively; adjusted relative risk, 0.97; 95 percent confidence interval, 0.81 to 1.16; P=0.73). At three months post partum, data on the women’s mood and quality of life, available for 573 women, revealed lower rates of depression and higher scores, consistent with improved health status, in the intervention group. Conclusions: Treatment of gestational diabetes reduces serious perinatal morbidity and may also improve the woman’s health-related quality of life.Caroline A. Crowther, Janet E. Hiller, John R. Moss, Andrew J. McPhee, William S. Jeffries and Jeffrey S. Robinso
Light Stop Decay in the MSSM with Minimal Flavour Violation
In supersymmetric scenarios with a light stop particle and a
small mass difference to the lightest supersymmetric particle (LSP) assumed to
be the lightest neutralino, the flavour changing neutral current decay
can be the dominant decay channel and can
exceed the four-body stop decay for certain parameter values. In the framework
of Minimal Flavour Violation (MFV) this decay is CKM-suppressed, thus inducing
long stop lifetimes. Stop decay length measurements at the LHC can then be
exploited to test models with minimal flavour breaking through Standard Model
Yukawa couplings. The decay width has been given some time ago by an
approximate formula, which takes into account the leading logarithms of the MFV
scale. In this paper we calculate the exact one-loop decay width in the
framework of MFV. The comparison with the approximate result exhibits
deviations of the order of 10% for large MFV scales due to the neglected
non-logarithmic terms in the approximate decay formula. The difference in the
branching ratios is negligible. The large logarithms have to be resummed. The
resummation is performed by the solution of the renormalization group
equations. The comparison of the exact one-loop result and the tree level
flavour changing neutral current decay, which incorporates the resummed
logarithms, demonstrates that the resummation effects are important and should
be taken into account.Comment: 29 page
A SM-like Higgs near 125 GeV in low energy SUSY: a comparative study for MSSM and NMSSM
Motivated by the recent LHC hints of a Higgs boson around 125 GeV, we assume
a SM-like Higgs with the mass 123-127 GeV and study its implication in low
energy SUSY by comparing the MSSM and NMSSM. We consider various experimental
constraints at 2-sigma level (including the muon g-2 and the dark matter relic
density) and perform a comprehensive scan over the parameter space of each
model. Then in the parameter space which is allowed by current experimental
constraints and also predicts a SM-like Higgs in 123-127 GeV, we examine the
properties of the sensitive parameters (like the top squark mass and the
trilinear coupling A_t) and calculate the rates of the di-photon signal and the
VV^* (V=W,Z) signals at the LHC. Our typical findings are: (i) In the MSSM the
top squark and A_t must be large and thus incur some fine-tuning, which can be
much ameliorated in the NMSSM; (ii) In the MSSM a light stau is needed to
enhance the di-photon rate of the SM-like Higgs to exceed its SM prediction,
while in the NMSSM the di-photon rate can be readily enhanced in several ways;
(iii) In the MSSM the signal rates of pp -> h -> VV^* at the LHC are never
enhanced compared with their SM predictions, while in the NMSSM they may get
enhanced significantly; (iv) A large part of the parameter space so far
survived will be soon covered by the expected XENON100(2012) sensitivity
(especially for the NMSSM).Comment: Version in JHEP (refs added
Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer
BACKGROUND: The clinical benefit of determining the status of HER-2/neu amplification in breast cancer patients is well accepted. Although immunohistochemistry (IHC) is the most frequently used method to assess the over-expression of HER-2 protein, fluorescent in-situ hybridization (FISH) is recognized as the "gold standard" for the determining of HER-2/neu status. The greatest discordance between the two methods occurs among breast tumors that receive an indeterminate IHC score of 2+. More recently, a real-time polymerase chain reaction (PCR) assay using the LightCycler(® )has been developed for quantifying HER-2/neu gene amplification. In this study, we evaluated the sensitivity and specificity of a commercially available LightCycler assay as it compares to FISH. To determine whether this assay provides an accurate alternative for the determination of HER-2/neu status, we focused primarily on tumors that were deemed indeterminate or borderline status by IHC. METHODS: Thirty-nine breast tumors receiving an IHC score of 2+ were evaluated by both FISH and LightCycler(® )technologies in order to determine whether quantitative real-time PCR provides an accurate alternative for the determination of HER-2/neu status. RESULTS: We found a high concordance (92%) between FISH and real-time PCR results. We also observed that 10% of these tumors were positive for gene amplification by both FISH and real-time PCR. CONCLUSION: The data show that the results obtained for the gene amplification of HER-2/neu by real-time PCR on the LightCycler(® )instrument is comparable to results obtained by FISH. These results therefore suggest that real-time PCR analysis, using the LightCycler(®), is a viable alternative to FISH for reassessing breast tumors which receive an IHC score of 2+, and that a combined IHC and real-time PCR approach for the determination of HER-2 status in breast cancer patients may be an effective and efficient strategy
HDP—A Novel Heme Detoxification Protein from the Malaria Parasite
When malaria parasites infect host red blood cells (RBC) and proteolyze hemoglobin, a unique, albeit poorly understood parasite-specific mechanism, detoxifies released heme into hemozoin (Hz). Here, we report the identification and characterization of a novel Plasmodium Heme Detoxification Protein (HDP) that is extremely potent in converting heme into Hz. HDP is functionally conserved across Plasmodium genus and its gene locus could not be disrupted. Once expressed, the parasite utilizes a circuitous “Outbound–Inbound” trafficking route by initially secreting HDP into the cytosol of infected RBC. A subsequent endocytosis of host cytosol (and hemoglobin) delivers HDP to the food vacuole (FV), the site of Hz formation. As Hz formation is critical for survival, involvement of HDP in this process suggests that it could be a malaria drug target
Rare Z-decay into light CP-odd Higgs bosons: a comparative study in different new physics models
Various new physics models predict a light CP-odd Higgs boson (labeled as
) and open up new decay modes for Z-boson, such as ,
and , which could be explored at the GigaZ option of
the ILC. In this work we investigate these rare decays in several new physics
models, namely the type-II two Higgs doublet model (type-II 2HDM), the
lepton-specific two Higgs doublet model (L2HDM), the nearly minimal
supersymetric standard model (nMSSM) and the next-to-minimal supersymmetric
standard model (NMSSM). We find that in the parameter space allowed by current
experiments, the branching ratios can reach for
(), for and for , which
implies that the decays and may be accessible
at the GigaZ option. Moreover, since different models predict different
patterns of the branching ratios, the measurement of these rare decays at the
GigaZ may be utilized to distinguish the models.Comment: Version in JHEP (discussions added, errors corrected
Comparative proteomic analysis of metabolically labelled proteins from Plasmodium falciparum isolates with different adhesion properties
The virulence of Plasmodium falciparum relates in part to the cytoadhesion characteristics of parasitized erythrocytes but the molecular basis of the different qualitative and quantitative binding phenotypes is incompletely understood. This paucity of information is due partly to the difficulty in working with membrane proteins, the variant nature of these surface antigens and their relatively low abundance. To address this two-dimensional (2D) protein profiles of closely related, but phenotypically different laboratory strains of P. falciparum have been characterized using proteomic approaches. Since the mature erythrocyte has no nucleus and no protein synthesis capability, metabolic labelling of proteins was used to selectively identify parasite proteins and increase detection sensitivity. A small number of changes (less than 10) were observed between four different P. falciparum laboratory strains with distinctive cytoadherence properties using metabolic labelling, with more parasite protein changes found in trophozoite iRBCs than ring stage. The combination of metabolic labelling and autoradiography can therefore be used to identify parasite protein differences, including quantitative ones, and in some cases to obtain protein identifications by mass spectrometry. The results support the suggestion that the membrane protein profile may be related to cytoadherent properties of the iRBCs. Most changes between parasite variants were differences in iso-electric point indicating differential protein modification rather than the presence or absence of a specific peptide
Kinematic Edges with Flavor Oscillation and Non-Zero Widths
Kinematic edges in cascade decays provide a probe of the masses of new
particles. In some new physics scenarios the decay chain involves intermediate
particles of different flavors that can mix and oscillate. We discuss the
implication of such oscillation, and in particular its interplay with the
non-zero widths of the particles. We derive explicit formulae for differential
decay rates involving both non-zero widths and oscillation, and show that in
the case where the mass difference between the intermediate particle is of the
order of their widths, both oscillation and width effects are important. An
examination of the physical observables contained in these differential decay
rates is provided. We calculate differential decay rates for cases in which the
intermediate particles are either scalars or fermions.Comment: 28 pages, 6 figure
Modulation of peritoneal macrophage activity by the saturation state of the fatty acid moiety of phosphatidylcholine
GC content around splice sites affects splicing through pre-mRNA secondary structures
<p>Abstract</p> <p>Background</p> <p>Alternative splicing increases protein diversity by generating multiple transcript isoforms from a single gene through different combinations of exons or through different selections of splice sites. It has been reported that RNA secondary structures are involved in alternative splicing. Here we perform a genomic study of RNA secondary structures around splice sites in humans (<it>Homo sapiens</it>), mice (<it>Mus musculus</it>), fruit flies (<it>Drosophila melanogaster</it>), and nematodes (<it>Caenorhabditis elegans</it>) to further investigate this phenomenon.</p> <p>Results</p> <p>We observe that GC content around splice sites is closely associated with the splice site usage in multiple species. RNA secondary structure is the possible explanation, because the structural stability difference among alternative splice sites, constitutive splice sites, and skipped splice sites can be explained by the GC content difference. Alternative splice sites tend to be GC-enriched and exhibit more stable RNA secondary structures in all of the considered species. In humans and mice, splice sites of first exons and long exons tend to be GC-enriched and hence form more stable structures, indicating the special role of RNA secondary structures in promoter proximal splicing events and the splicing of long exons. In addition, GC-enriched exon-intron junctions tend to be overrepresented in tissue-specific alternative splice sites, indicating the functional consequence of the GC effect. Compared with regions far from splice sites and decoy splice sites, real splice sites are GC-enriched. We also found that the GC-content effect is much stronger than the nucleotide-order effect to form stable secondary structures.</p> <p>Conclusion</p> <p>All of these results indicate that GC content is related to splice site usage and it may mediate the splicing process through RNA secondary structures.</p
- …